Science & Medicine


Special Bulletin – Incyte jacks up Jakafi price

What’s really behind Incyte’s decision to boost the price of Jakafi – its MF drug already considered not too pricey for the UK and cost-ineffective – on the heels of patient appeals to lower the cost.

The story, Incyte’s official response and the reactions here.

Comments on: "Jakafi price increase – the story" (1)

  1. From now on I will no longer call the company Incyte rather I will call them Insult.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: